Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CALGB E2810 Principal Investigator: Picus, Joel
Title: Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients with Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastasectomy
Phase: III Disease Site: Kidney
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions		 St. Peters
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this study is to determine whether taking an oral drug known as pazopanib will reduce the risk of the cancer recurring in the future.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)